Literature DB >> 33544116

Promotion of cancer cell stemness by Ras.

Rohan Chippalkatti1, Daniel Abankwa1.   

Abstract

Cancer stem cells (CSC) may be the most relevant and elusive cancer cell population, as they have the exquisite ability to seed new tumors. It is plausible, that highly mutated cancer genes, such as KRAS, are functionally associated with processes contributing to the emergence of stemness traits. In this review, we will summarize the evidence for a stemness driving activity of oncogenic Ras. This activity appears to differ by Ras isoform, with the highly mutated KRAS having a particularly profound impact. Next to established stemness pathways such as Wnt and Hedgehog (Hh), the precise, cell cycle dependent orchestration of the MAPK-pathway appears to relay Ras activation in this context. We will examine how non-canonical activities of K-Ras4B (hereafter K-Ras) could be enabled by its trafficking chaperones calmodulin and PDE6D/PDEδ. Both dynamically localize to the cellular machinery that is intimately linked to cell fate decisions, such as the primary cilium and the centrosome. Thus, it can be speculated that oncogenic K-Ras disrupts fundamental polarized signaling and asymmetric apportioning processes that are necessary during cell differentiation.
© 2021 The Author(s).

Entities:  

Keywords:  KRAS; cancer stem cells; centrosomes; cilia; trafficking

Mesh:

Substances:

Year:  2021        PMID: 33544116      PMCID: PMC7925005          DOI: 10.1042/BST20200964

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  101 in total

Review 1.  Molecular mechanisms of asymmetric divisions in mammary stem cells.

Authors:  Angela Santoro; Thalia Vlachou; Manuel Carminati; Pier Giuseppe Pelicci; Marina Mapelli
Journal:  EMBO Rep       Date:  2016-11-21       Impact factor: 8.807

2.  The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

Authors:  Joanna R Kovalski; Aparna Bhaduri; Ashley M Zehnder; Poornima H Neela; Yonglu Che; Glenn G Wozniak; Paul A Khavari
Journal:  Mol Cell       Date:  2019-01-10       Impact factor: 17.970

3.  K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function.

Authors:  B Alvarez-Moya; C López-Alcalá; M Drosten; O Bachs; N Agell
Journal:  Oncogene       Date:  2010-08-30       Impact factor: 9.867

4.  Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.

Authors:  Byoung-San Moon; Woo-Jeong Jeong; Jieun Park; Tae Il Kim; Do Sik Min; Kang-Yell Choi
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 13.506

5.  Reduction of oxidative stress during recovery accelerates normalization of primary cilia length that is altered after ischemic injury in murine kidneys.

Authors:  Jee In Kim; Jinu Kim; Hee-Seong Jang; Mi Ra Noh; Joshua H Lipschutz; Kwon Moo Park
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-20

6.  Calmodulin disrupts plasma membrane localization of farnesylated KRAS4b by sequestering its lipid moiety.

Authors:  Benjamin M M Grant; Masahiro Enomoto; Sung-In Back; Ki-Young Lee; Teklab Gebregiworgis; Noboru Ishiyama; Mitsuhiko Ikura; Christopher B Marshall
Journal:  Sci Signal       Date:  2020-03-31       Impact factor: 8.192

7.  Dynamic redistribution of calmodulin in HeLa cells during cell division as revealed by a GFP-calmodulin fusion protein technique.

Authors:  C J Li; R Heim; P Lu; Y Pu; R Y Tsien; D C Chang
Journal:  J Cell Sci       Date:  1999-05       Impact factor: 5.285

8.  Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1.

Authors:  Itziar M D Posada; Benoit Lectez; Farid A Siddiqui; Christina Oetken-Lindholm; Mukund Sharma; Daniel Abankwa
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

9.  Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.

Authors:  Kouichi Tabu; Taichi Kimura; Ken Sasai; Lei Wang; Norihisa Bizen; Hiroshi Nishihara; Tetsuya Taga; Shinya Tanaka
Journal:  Mol Cancer       Date:  2010-02-19       Impact factor: 27.401

Review 10.  The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy.

Authors:  Jimin Yuan; Xiaoduo Dong; Jiajun Yap; Jiancheng Hu
Journal:  J Hematol Oncol       Date:  2020-08-17       Impact factor: 17.388

View more
  4 in total

1.  Expression of M3 muscarinic acetylcholine receptors in gastric cancer.

Authors:  Alina Maria Mehedinţeanu; Cecil Sorin Mirea; Puiu Olivian Stovicek; Michael Schenker; Marius Ionuţ Stancu; Ana Maria Ciurea; Liliana Streba; Anca Maria Istrate-Ofiţeru; Teodor Nicuşor Sas; Cristin Constantin Vere
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

2.  Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells.

Authors:  Ganesh Babu Manoharan; Sunday Okutachi; Daniel Abankwa
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  ARL2 is required for homologous recombination repair and colon cancer stem cell survival.

Authors:  Hani Lee; SeokGyeong Choi; Sojung Ha; Sukjoon Yoon; Woo-Young Kim
Journal:  FEBS Open Bio       Date:  2022-05-24       Impact factor: 2.792

Review 4.  Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems.

Authors:  Aadya Nayak; Neerada Meenakshi Warrier; Praveen Kumar
Journal:  Stem Cell Rev Rep       Date:  2022-07-25       Impact factor: 6.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.